7RJ-26096-42908
3 vaccinations
3 coded responses
36 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 462 / IN
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Registered in v-safe
-
2021-03-19
Dose 1 — Pfizer-BioNTech
- 2021-03-19
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-03-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Itching · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-03-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Itching · Headache, Fatigue or tirednessAdult check-in
-
2021-03-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, Nausea, VomitingAdult check-in
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-04-02
-
2021-04-09
Dose 2 — Pfizer-BioNTech
- 2021-04-09
-
2021-04-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness, Nausea, VomitingAdult check-in
- 2021-04-11
- 2021-04-12
- 2021-04-13
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-04-15
- 2021-04-18
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-07-09
- 2021-10-08
-
2021-10-15
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-17
- 2021-10-19
- 2021-10-20
- 2021-10-21
- 2021-10-24
-
2021-10-29
Survey response — day 14, dose 3MedDRA: Ageusia, Anosmia, Cough, Nasal congestion, Rhinorrhoea — Feeling: FairFree text: Runny/stuffy nose, loss of taste and smell in short bursts, coughMedDRA releases: 2024-11 · check-in free text available
-
2021-11-05
Survey response — day 21, dose 3MedDRA: Cough, Nasal congestion, Respiratory tract congestion — Feeling: GoodFree text: Congestion. Cough. Stuffy nose.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-12
- 2021-11-19
- 2021-11-26
-
2022-01-14
Survey response — 3 months, dose 3MedDRA: COVID-19, Pregnancy, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Pregnancy. Covid. · Healthcare visit (other): UltrasoundMedDRA releases: 2024-11 · check-in free text available
-
2022-01-14
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-01-18
- 2022-04-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Pfizer-BioNTech | |
| 2 | 2021-04-09 | Pfizer-BioNTech | |
| 3 | 2021-10-15 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-14 | Unsuccessful |
Free text
Release 10 — day 14, dose 3
Symptoms: Runny/stuffy nose, loss of taste and smell in short bursts, cough
Release 10 — day 21, dose 3
Symptoms: Congestion. Cough. Stuffy nose.
Release 10 — 3 months, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release